Literature DB >> 20452335

Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet).

Manal Mohamed Elhassan Taha1, Ahmad Bustamam Abdul, Rasedee Abdullah, Tengku Azmi Tengku Ibrahim, Siddig Ibrahim Abdelwahab, Syam Mohan.   

Abstract

Zerumbone (ZER), a monosesquiterpene found in the subtropical ginger (Zingiber zerumbet Smith), possesses antiproliferative properties to several cancer cells lines, including the cervical, skin and colon cancers. In this study, the antitumourigenic effects of ZER were assessed in rats induced to develop liver cancer with a single intraperitoneal injection of diethylnitrosamine (DEN, 200 mg/kg) and dietary 2-acetylaminofluorene (AAF) (0.02%). The rats also received intraperitoneal ZER injections at 15, 30 or 60 mg/kg body wt. twice a week for 11 weeks, beginning week four post-DEN injection. The hepatocytes of positive control (DEN/AAF) rats were smaller with larger hyperchromatic nuclei than normal, showing cytoplasmic granulation and intracytoplasmic violaceous material, which were characteristics of hepatocarcinogenesis. Histopathological evaluations showed that ZER protects the rat liver from the carcinogenic effects of DEN and AAF. Serum alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (AP) and alpha-fetoprotein (AFP) were significantly lower (P<0.05) in ZER-treated than untreated rats with liver cancer. The liver malondialdehyde (MDA) concentrations significantly (P<0.05) increased in the untreated DEN/AAF rats indicating hepatic lipid peroxidation. There was also significant (P<0.05) reduction in the hepatic tissue glutathione (GSH) concentrations. The liver sections of untreated DEN/AAF rats also showed abundant proliferating cell nuclear antigen (PCNA), while in ZER-treated rats the expression of this antigen was significantly (P<0.05) lowered. By the TUNEL assay, there were significantly (P<0.05) higher numbers of apoptotic cells in DEN/AAF rats treated with ZER than those untreated. Zerumbone treatment had also increased Bax and decreased Bcl-2 protein expression in the livers of DEN/AAF rats, which suggested increased apoptosis. Even after 11 weeks of ZER treatment, there was no evidence of abnormality in the liver of normal rats. This study suggests that ZER reduces oxidative stress, inhibits proliferation, induces mitochondria-regulated apoptosis, thus minimising DEN/AAF-induced carcinogenesis in rat liver. Therefore, ZER has great potential in the treatment of liver cancers. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452335     DOI: 10.1016/j.cbi.2010.04.029

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  29 in total

1.  Zerumbone causes Bax- and Bak-mediated apoptosis in human breast cancer cells and inhibits orthotopic xenograft growth in vivo.

Authors:  Anuradha Sehrawat; Julie A Arlotti; Akira Murakami; Shivendra V Singh
Journal:  Breast Cancer Res Treat       Date:  2012-10-06       Impact factor: 4.872

2.  Terpenoids as potential chemopreventive and therapeutic agents in liver cancer.

Authors:  Roslin J Thoppil; Anupam Bishayee
Journal:  World J Hepatol       Date:  2011-09-27

3.  Cytotoxicity and genotoxicity of zingiberene on different neuron cell lines in vitro.

Authors:  Basak Togar; Hasan Turkez; Abdulgani Tatar; Ahmet Hacimuftuoglu; Fatime Geyikoglu
Journal:  Cytotechnology       Date:  2014-05-07       Impact factor: 2.058

4.  Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signaling.

Authors:  Mohamed M Sayed-Ahmed; Abdulaziz M Aleisa; Salim S Al-Rejaie; Abdulaziz A Al-Yahya; Othman A Al-Shabanah; Mohamed M Hafez; Mahmoud N Nagi
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

5.  Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells.

Authors:  Anuradha Sehrawat; Kozue Sakao; Shivendra V Singh
Journal:  Breast Cancer Res Treat       Date:  2014-07-20       Impact factor: 4.872

6.  In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa.

Authors:  Moustafa Fathy; Toshio Nikaido
Journal:  Environ Health Prev Med       Date:  2013-04-23       Impact factor: 3.674

7.  Dietary zerumbone prevents against ultraviolet B-induced cataractogenesis in the mouse.

Authors:  Bo-Yie Chen; David Pei-Cheng Lin; Kuo-Chen Su; Yi-Ling Chen; Chia-Yung Wu; Mei-Ching Teng; Yuan-Ting Tsai; Chi-Yun Sun; Soo-Ray Wang; Han-Hsin Chang
Journal:  Mol Vis       Date:  2011-03-12       Impact factor: 2.367

8.  Cucurbitacin L 2-O-β-Glucoside Demonstrates Apoptogenesis in Colon Adenocarcinoma Cells (HT-29): Involvement of Reactive Oxygen and Nitrogen Species Regulation.

Authors:  Siddig Ibrahim Abdelwahab; Loiy Elsir Ahmed Hassan; Amin M S Abdul Majid; Sakina M Ahmed Yagi; Syam Mohan; Manal Mohamed Elhassan Taha; Syahida Ahmad; Cheah Shiau Chuen; Putri Narrima; Mohd Mustafa Rais; Suvitha Syam; Bushra Abdulkarim Moharam; A Hamid A Hadi
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-26       Impact factor: 2.629

9.  Inclusion Complex of Zerumbone with Hydroxypropyl- β -Cyclodextrin Induces Apoptosis in Liver Hepatocellular HepG2 Cells via Caspase 8/BID Cleavage Switch and Modulating Bcl2/Bax Ratio.

Authors:  Nabilah Muhammad Nadzri; Ahmad Bustamam Abdul; Mohd Aspollah Sukari; Siddig Ibrahim Abdelwahab; Eltayeb E M Eid; Syam Mohan; Behnam Kamalidehghan; Theebaa Anasamy; Kuan Beng Ng; Suvitha Syam; Ismail Adam Arbab; Heshu Sulaiman Rahman; Hapipah Mohd Ali
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-08       Impact factor: 2.629

10.  Dentatin Induces Apoptosis in Prostate Cancer Cells via Bcl-2, Bcl-xL, Survivin Downregulation, Caspase-9, -3/7 Activation, and NF-κB Inhibition.

Authors:  Ismail Adam Arbab; Chung Yeng Looi; Ahmad Bustamam Abdul; Foo Kit Cheah; Won Fen Wong; Mohd Aspollah Sukari; Rasedee Abdullah; Syam Mohan; Suvitha Syam; Aditya Arya; Manal Mohamed Elhassan Taha; Bushra Muharram; Mohd Rais Mustafa; Siddig Ibrahim Abdelwahab
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.